GNH USA

Europe — EMA

Wezenla

Wezenla (ustekinumab) is a prescription biologic used to treat immune-mediated conditions like psoriasis and psoriatic arthritis. It works by targeting specific

Ustekinumab

Request sourcing

1
Pack/s

What is Ustekinumab?

Wezenla (ustekinumab) is a prescription biologic used to treat immune-mediated conditions like psoriasis and psoriatic arthritis. It works by targeting specific proteins in the immune system. This medication is administered via subcutaneous injection. Always follow healthcare provider guidance when using Wezenla.

What is Ustekinumab used for?

Wezenla (ustekinumab) is used to reduce symptoms of moderate to severe plaque psoriasis and active psoriatic arthritis. It is also prescribed for moderate to severe Crohn’s disease and ulcerative colitis in adults. This biologic helps manage immune responses to improve skin and joint health. Patients often ask, 'What is Wezenla used for?' to understand its role in treatment plans.

What are the side effects of Ustekinumab?

Wezenla may help reduce skin plaques, joint pain, and inflammation over time. Some users notice improved mobility and clearer skin after regular use. Individual responses vary, and results depend on consistent adherence to the prescribed schedule. Effects are typically gradual rather than immediate.

What precautions apply to Ustekinumab?

Store Wezenla in the refrigerator until ready to use, avoiding freezing or exposure to extreme heat. Keep the medication in its original packaging to protect it from light. Discard any unused portions as directed by a healthcare professional. Always check the liquid for particles or discoloration before use.

What does Ustekinumab interact with?

Wezenla may interact with other biologics or immunosuppressants, so inform your doctor about all medications you take. Live vaccines should be avoided while using Wezenla due to potential reduced effectiveness. Alcohol and certain supplements may also interact; consult a healthcare provider for personalized advice.

Frequently asked questions

What is Wezenla used for?+
Wezenla is used to treat moderate to severe plaque psoriasis, active psoriatic arthritis, and certain inflammatory bowel diseases like Crohn’s disease and ulcerative colitis.
How is Wezenla administered?+
Wezenla is given as a subcutaneous injection, typically under the skin of the thigh or abdomen. A healthcare provider or patient may administer it after proper training.
Who should avoid Wezenla?+
People with active infections or a history of severe allergic reactions to ustekinumab should avoid this medication. Always consult a doctor for personalized advice.
Can I use Wezenla while pregnant?+
The safety of Wezenla during pregnancy has not been fully established. Discuss potential risks and benefits with your healthcare provider before use.
How often is Wezenla given?+
The dosing schedule for Wezenla varies by condition. Typically, it starts with an initial dose followed by maintenance doses every 8 to 12 weeks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ustekinumab
Route
Subcutaneous Use
Manufacturer
Amgen Technology (Ireland) Uc
Origin
EU

Related products